article thumbnail

Mets Owner Steve Cohen Donates $5 Million in Support of Psychedelics Research

Veriheal

The donation was made through the Steven & Alexandra Cohen Foundation —an organization founded by the hedge fund billionaire in 2001 to promote philanthropy and community service. If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 95
article thumbnail

There’s A Petition Underway In The UK To Get Parliament To “Reschedule psilocybin for medical research on untreatable conditions” 96K Signatures Still Needed

Cannabis Law Report

Move psilocybin (the psychoactive compound found in “magic mushrooms”) to Schedule 2 of the Misuse of Drugs Regulations 2001, reducing unnecessary barriers to scientific research which slow the development of new and vital treatments for a range of physical and mental health conditions in the UK. Sign this petition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK Article: Why Don’t We Just… reschedule psilocybin?

Cannabis Law Report

Psychedelic medicine could provide much needed treatment options for some mental health and neurological disorders in the near future. There are a number of differences between PAP and current treatment approaches. This is because of the status of psychedelics as Schedule 1 drugs, under the Misuse of Drugs Regulations 2001.

article thumbnail

UK: Tory MP Crispin Blunt At Loggerheads With The Home Office Over Psilocybin Research

Cannabis Law Report

This change would mean it would be easier to run trials on its use in mental health treatments. The Prime Minister had already approved the rescheduling of psilocybin for exploring its potential as a treatment for depression, which he informed Mr Blunt in a meeting in May. Source: [link].

article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

article thumbnail

Terpene Spotlight: Pulegone

FloridaMarijuana.net

Edition (2001): Medicinal plants contain a variety of bioactive compounds such as terpenes, which are composed of essential oils. The trained staff at the Medical Marijuana Treatment Center will assist each patient in selecting the appropriate cannabis products. According to P.M.

Terpenes 172
article thumbnail

Best strains and terpenes for nausea

The Cannigma

Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. A 2016 preclinical rodent trial found that CBDA was “1000 times more potent than CBD in reducing acute nausea” and “may be a highly effective treatment for acute nausea.” Limonene is the dominant terpene in lemon oil.

Terpenes 115